openPR Logo
Press release

Immunology Market Size, Trends, Growth, Opportunities 2024-2032 | AbbVie Inc., Janssen Global Services, LLC, F. Hoffmann-La Roche Ltd, and Novartis AG

10-11-2024 08:03 AM CET | Health & Medicine

Press release from: Fortune Business Insights

Immunology Market Size, Trends, Growth, Opportunities

The global immunology market size was valued at USD 97.58 billion in 2023. The market is projected to grow from USD 103.18 billion in 2024 to USD 257.39 billion by 2032, exhibiting a CAGR of 12.1% during the forecast period (2024-2032).

The immunology market is experiencing significant growth as advancements in treatments for chronic immune disorders offer patients new hope. This press release explores a recent key industry development, leading segment, and future outlook for this vital medical field.

๐——๐—ถ๐˜€๐—ฐ๐—ผ๐˜ƒ๐—ฒ๐—ฟ ๐—ช๐—ต๐—ฎ๐˜ ๐—ฌ๐—ผ๐˜‚'๐—ฟ๐—ฒ ๐— ๐—ถ๐˜€๐˜€๐—ถ๐—ป๐—ด: ๐—š๐—ฒ๐˜ ๐—ฎ ๐—™๐—ฟ๐—ฒ๐—ฒ ๐—ฅ๐—ฒ๐—ฝ๐—ผ๐—ฟ๐˜ (๐—ฃ๐——๐—™) ๐—ฆ๐—ฎ๐—บ๐—ฝ๐—น๐—ฒ: https://www.fortunebusinessinsights.com/enquiry/sample/immunology-market-100657

๐—จ๐—–๐—•'๐˜€ ๐—•๐—œ๐— ๐—ญ๐—˜๐—Ÿ๐—ซ ๐—ฆ๐—ต๐—ผ๐˜„๐˜€ ๐—ฃ๐—ฟ๐—ผ๐—บ๐—ถ๐˜€๐—ฒ ๐—ณ๐—ผ๐—ฟ ๐—”๐—ป๐—ธ๐˜†๐—น๐—ผ๐˜€๐—ถ๐—ป๐—ด ๐—ฆ๐—ฝ๐—ผ๐—ป๐—ฑ๐˜†๐—น๐—ถ๐˜๐—ถ๐˜€:

In a positive development for the immunology market, UCB announced positive results from its long-term Phase 2b study for BIMZELX in November 2023. This drug demonstrated efficacy in treating ankylosing spondylitis, a chronic inflammatory disease affecting the spine and joints. The study suggests BIMZELX has the potential to improve symptoms and maintain quality of life for patients for up to five years. This research highlights the ongoing innovation in the immunology market, leading to potentially life-changing treatments.

๐—ง๐—ผ๐—ฝ ๐—ฃ๐—น๐—ฎ๐˜†๐—ฒ๐—ฟ๐˜€ ๐—ถ๐—ป ๐˜๐—ต๐—ฒ ๐—œ๐—บ๐—บ๐˜‚๐—ป๐—ผ๐—น๐—ผ๐—ด๐˜† ๐— ๐—ฎ๐—ฟ๐—ธ๐—ฒ๐˜:

โ€ข AbbVie, Inc. (U.S.)
โ€ข Janssen Global Services, LLC (U.S.) (Subsidiary of Johnson & Johnson)
โ€ข Eli Lilly and Company (U.S.)
โ€ข Novartis AG (Switzerland)
โ€ข Pfizer Inc. (U.S.)
โ€ข Bristol-Myers Squibb Company (U.S.)
โ€ข Merck Sharp & Dohme Corp. (U.S.)
โ€ข F. Hoffmann-La Roche Ltd. (Switzerland)
โ€ข Amgen Inc. (U.S.)
โ€ข Astellas Pharma Inc. (Japan)
โ€ข UCB SA (Belgium)

๐— ๐—ฎ๐—ฟ๐—ธ๐—ฒ๐˜ ๐——๐—ฟ๐—ถ๐˜ƒ๐—ฒ๐—ฟ๐˜€ ๐—ฎ๐—ป๐—ฑ ๐—ฅ๐—ฒ๐˜€๐˜๐—ฟ๐—ฎ๐—ถ๐—ป๐˜๐˜€:

Several factors are driving the growth of the immunology market:

โ€ข ๐—ฅ๐—ถ๐˜€๐—ถ๐—ป๐—ด ๐—ฃ๐—ฟ๐—ฒ๐˜ƒ๐—ฎ๐—น๐—ฒ๐—ป๐—ฐ๐—ฒ ๐—ผ๐—ณ ๐—”๐˜‚๐˜๐—ผ๐—ถ๐—บ๐—บ๐˜‚๐—ป๐—ฒ ๐——๐—ถ๐˜€๐—ฒ๐—ฎ๐˜€๐—ฒ๐˜€: The increasing incidence of autoimmune diseases, such as rheumatoid arthritis, psoriasis, and inflammatory bowel disease, is fueling demand for effective immunology treatments.
โ€ข ๐—œ๐—บ๐—ฝ๐—ฟ๐—ผ๐˜ƒ๐—ฒ๐—ฑ ๐——๐—ถ๐—ฎ๐—ด๐—ป๐—ผ๐˜€๐˜๐—ถ๐—ฐ ๐—ง๐—ฒ๐—ฐ๐—ต๐—ป๐—ถ๐—พ๐˜‚๐—ฒ๐˜€: Advancements in diagnostic tools allow for earlier detection and more targeted treatment of immune disorders.
โ€ข ๐—š๐—ฟ๐—ผ๐˜„๐—ถ๐—ป๐—ด ๐—œ๐—ป๐˜ƒ๐—ฒ๐˜€๐˜๐—บ๐—ฒ๐—ป๐˜ ๐—ถ๐—ป ๐—ฅ๐—ฒ๐˜€๐—ฒ๐—ฎ๐—ฟ๐—ฐ๐—ต ๐—ฎ๐—ป๐—ฑ ๐——๐—ฒ๐˜ƒ๐—ฒ๐—น๐—ผ๐—ฝ๐—บ๐—ฒ๐—ป๐˜: Increased investment in research is leading to the development of new and improved immunology therapies, including biologics and gene therapies.

However, certain challenges remain:

โ€ข ๐—›๐—ถ๐—ด๐—ต ๐—–๐—ผ๐˜€๐˜ ๐—ผ๐—ณ ๐—ง๐—ฟ๐—ฒ๐—ฎ๐˜๐—บ๐—ฒ๐—ป๐˜๐˜€: Immunology treatments can be expensive, posing an access barrier for some patients.
โ€ข ๐—”๐˜‚๐˜๐—ผ๐—ถ๐—บ๐—บ๐˜‚๐—ป๐—ฒ ๐——๐—ถ๐˜€๐—ฒ๐—ฎ๐˜€๐—ฒ ๐—–๐—ผ๐—บ๐—ฝ๐—น๐—ฒ๐˜…๐—ถ๐˜๐˜†:
The complex nature of autoimmune diseases necessitates ongoing research to develop more effective and personalized treatment approaches.
โ€ข ๐—ฃ๐—ผ๐˜๐—ฒ๐—ป๐˜๐—ถ๐—ฎ๐—น ๐—ฆ๐—ถ๐—ฑ๐—ฒ ๐—˜๐—ณ๐—ณ๐—ฒ๐—ฐ๐˜๐˜€: Immunology treatments can have side effects, requiring careful monitoring and management.

๐—™๐—ผ๐—ฟ ๐—™๐˜‚๐—น๐—น ๐—ฅ๐—ฒ๐—ฝ๐—ผ๐—ฟ๐˜ ๐—–๐—ผ๐˜ƒ๐—ฒ๐—ฟ๐—ฎ๐—ด๐—ฒ ๐—ฉ๐—ถ๐˜€๐—ถ๐˜: https://www.fortunebusinessinsights.com/enquiry/ask-for-customization/immunology-market-100657

๐— ๐—ฎ๐—ฟ๐—ธ๐—ฒ๐˜ ๐—ฅ๐—ฒ๐—ฝ๐—ผ๐—ฟ๐˜ ๐—–๐—ผ๐˜ƒ๐—ฒ๐—ฟ๐—ฎ๐—ด๐—ฒ:

For a comprehensive understanding of the immunology market, Fortune Business Insights' report offers in-depth analysis on:

โ€ข ๐— ๐—ฎ๐—ฟ๐—ธ๐—ฒ๐˜ ๐—š๐—ฟ๐—ผ๐˜„๐˜๐—ต ๐—ฃ๐—ฟ๐—ผ๐—ท๐—ฒ๐—ฐ๐˜๐—ถ๐—ผ๐—ป๐˜€: The report provides detailed market size and growth forecasts for the immunology market over the forecast period.
โ€ข ๐— ๐—ฎ๐—ฟ๐—ธ๐—ฒ๐˜ ๐—ฆ๐—ฒ๐—ด๐—บ๐—ฒ๐—ป๐˜๐—ฎ๐˜๐—ถ๐—ผ๐—ป: The report segments the market based on drug class (monoclonal antibodies, immunosuppressants, fusion proteins), application (rheumatoid arthritis, psoriasis, inflammatory bowel disease, allergies, asthma), and end-user (hospitals, clinics, ambulatory surgical centres).
โ€ข ๐—–๐—ผ๐—บ๐—ฝ๐—ฒ๐˜๐—ถ๐˜๐—ถ๐˜ƒ๐—ฒ ๐—Ÿ๐—ฎ๐—ป๐—ฑ๐˜€๐—ฐ๐—ฎ๐—ฝ๐—ฒ: The report identifies key players in the market and analyzes their competitive strategies.
โ€ข ๐—ฅ๐—ฒ๐—ด๐—ถ๐—ผ๐—ป๐—ฎ๐—น ๐—œ๐—ป๐˜€๐—ถ๐—ด๐—ต๐˜๐˜€: The report provides insights into the growth potential of immunology treatments in different geographical regions.

๐— ๐—ผ๐—ป๐—ผ๐—ฐ๐—น๐—ผ๐—ป๐—ฎ๐—น ๐—”๐—ป๐˜๐—ถ๐—ฏ๐—ผ๐—ฑ๐—ถ๐—ฒ๐˜€ ๐——๐—ผ๐—บ๐—ถ๐—ป๐—ฎ๐˜๐—ฒ ๐˜๐—ต๐—ฒ ๐— ๐—ฎ๐—ฟ๐—ธ๐—ฒ๐˜:

Within the immunology market, the monoclonal antibody (mAb) segment holds the leading position. Monoclonal antibodies are lab-made proteins that target specific components of the immune system, offering a more targeted approach to treating immune disorders.

๐—” ๐—–๐—ผ๐—บ๐—ฝ๐—ฒ๐˜๐—ถ๐˜๐—ถ๐˜ƒ๐—ฒ ๐—Ÿ๐—ฎ๐—ป๐—ฑ๐˜€๐—ฐ๐—ฎ๐—ฝ๐—ฒ:

The immunology market exhibits a dynamic and competitive landscape. Established pharmaceutical companies are at the forefront of research and development, while smaller biotechnology firms are emerging with novel immunology therapies. This competition fosters innovation and drives advancements in immunology treatments.

๐—ง๐—ต๐—ฒ ๐—™๐˜‚๐˜๐˜‚๐—ฟ๐—ฒ ๐—ผ๐—ณ ๐—œ๐—บ๐—บ๐˜‚๐—ป๐—ผ๐—น๐—ผ๐—ด๐˜†:

The immunology market is poised for continued growth as research efforts unlock new avenues for treating complex immune disorders. With advancements in diagnostics, targeted therapies, and personalized medicine, the future of immunology holds significant promise for improving the lives of millions of patients worldwide.

๐—–๐˜‚๐˜€๐˜๐—ผ๐—บ๐—ถ๐˜‡๐—ฒ ๐—ง๐—ต๐—ถ๐˜€ ๐—ฅ๐—ฒ๐—ฝ๐—ผ๐—ฟ๐˜ ๐—”๐—ฐ๐—ฐ๐—ผ๐—ฟ๐—ฑ๐—ถ๐—ป๐—ด ๐—ง๐—ผ ๐—ฌ๐—ผ๐˜‚๐—ฟ ๐—–๐—ผ๐—ป๐˜ƒ๐—ฒ๐—ป๐—ถ๐—ฒ๐—ป๐—ฐ๐—ฒ: https://www.fortunebusinessinsights.com/enquiry/ask-for-customization/immunology-market-100657

Contact Us:
Fortune Business Insightsโ„ข Pvt. Ltd.
9th Floor, Icon Tower,
Baner, Pune-411045,
Maharashtra, India.
Phone:
U.S.:+1 833 909 2966 (Toll-Free)
U.K.: +44 808 502 0280 (Toll-Free)
APAC +91 744 740 1245
Email: sales@fortunebusinessinsights.com

๐€๐›๐จ๐ฎ๐ญ ๐”๐ฌ:
Fortune Business Insightsโ„ข offers expert corporate analysis and accurate data, helping organizations make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Immunology Market Size, Trends, Growth, Opportunities 2024-2032 | AbbVie Inc., Janssen Global Services, LLC, F. Hoffmann-La Roche Ltd, and Novartis AG here

News-ID: 3687912 • Views: โ€ฆ

More Releases from Fortune Business Insights

Future of Renewable Energy Market Insights: Growth Drivers, and Regional Developments
Future of Renewable Energy Market Insights: Growth Drivers, and Regional Develop โ€ฆ
Global Renewable Energy Market Overview The global renewable energy market size was valued at USD 954 billion in 2023. The market is projected to grow from USD 1,020.94 billion in 2024 to USD 1,574.17 billion by 2032, exhibiting a CAGR of 5.56% during the forecast period. Asia Pacific dominated the renewable energy market with a market share of 67.76% in 2023. The Renewable energy market in the U.S. is projected toโ€ฆ
DC Drives Market Overview: Opportunities, Growth Drivers, and Key Applications
DC Drives Market Overview: Opportunities, Growth Drivers, and Key Applications
Market Overview The global DC drives market size was valued at USD 4.34 billion in 2018 and is projected to reach USD 9.23 billion by 2032, exhibiting a CAGR of 5.59% during the forecast period of 2019-2032. Asia Pacific dominated the global market with a share of 28.8% in 2018. The DC drives market in the U.S. is projected to grow significantly, reaching an estimated value of USD 1.59 billion byโ€ฆ
Humanoid Robots Market: An In-depth B2B Analysis of Size, Share, and Future Growth
Humanoid Robots Market: An In-depth B2B Analysis of Size, Share, and Future Grow โ€ฆ
Brief Market Overview: The global humanoid robots market is rapidly transitioning from a nascent field into a major growth sector, with its value escalating from USD 2.43 billion in 2023 to a projected USD 66.0 billion by 2032, demonstrating a remarkable CAGR of 45.5%. These complex machines, which merge mechanical, electrical, and software engineering, are moving beyond research labs into real-world applications across industrial, service, and household sectors. This explosive growthโ€ฆ
Methanol Market Poised for Remarkable Growth, set to Reach USD 46.32 billion by 2032 with a CAGR of 4.5%.
Methanol Market Poised for Remarkable Growth, set to Reach USD 46.32 billion by โ€ฆ
The global methanol market size was valued at USD 31.26 billion in 2023. It is projected to grow from USD 32.70 billion in 2024 to USD 46.32 billion by 2032, exhibiting a CAGR of 4.5% during the forecast period. The global methanol market size is set to gain traction from the urgent need to lower environmental pollution caused by the surging usage of heavy fuels, such as diesel and gasoline. Pollutionโ€ฆ

All 5 Releases


More Releases for Immunology

Alta DiagnoTech Releases ELISA Kits for IVD Immunology Testing
Alta DiagnoTech announced the release of its highly sensitive and reliable ELISA kits specifically designed for IVD in immunology testing. New York, USA - January 31, 2025 - As a top supplier of clinical diagnostic products, Alta DiagnoTech introduced ELISA (Enzyme-Linked Immunosorbent Assay) kits designed for in vitro diagnostics (IVD) applications in immunology testing due to their high sensitivity and reliability. Through this initiative Alta DiagnoTech intends to boost diagnostic performanceโ€ฆ
Empowering Immunology: Creative Biolabs' Streamlined Pathway for IgE Antibodies
The success of their efforts to utilize the power of antibody engineering technologies has now permitted Creative Biolabs to include the anti-IgE antibody among its offerings. New York, USA - November 13, 2024 - The current situation leads us to believe that the value of IgE antibodies [https://non-igg-ab.creative-biolabs.com/category-ige-344.htm] in immunology research has grown significantly. "What makes IgE antibodies fascinating is the fact that they not only identify the pathological mechanisms ofโ€ฆ
Immunology Drugs Market Research Report 2023 | InsightAce Analytic
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " Global Immunology Drugs Market By Drug Class (Monoclonal antibodies, Fusion Proteins, Immunosuppressants, Polyclonal antibodies, and Other Drug classes), Distribution Channel(Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others), Disease Indications (Rheumatoid Arthritis, Psoriatic Arthritis, Plaque Psoriasis, Ankylosing Spondylitis, Inflammatory Bowel Disease, and Other disease Indication))- Trends, Industry Competition Analysis, Revenue and Forecast To 2030." According to theโ€ฆ
Immunology Market - Shaping the Immune Landscape: Transforming Healthcare with C โ€ฆ
Newark, New Castle, USA - new report, titled Immunology Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Immunology market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Immunology market. The report offers an overview of the market, which briefly describes theโ€ฆ
Immunology Biosimilars Market Boosting the Healthcare Industry Worldwide
A biosimilar medicine possesses similar pharmacokinetic and mode of action as an original biological medicine that has already been approved for therapeutic use. Biosimilars are made from a living organism such as bacteria and yeast or can also be derived from small molecules such as human insulin, erythropoietin, and monoclonal antibodies via recombinant DNA and gene expression technologies. Biosimilars are developed only when original biological medicines are commercially expired andโ€ฆ
16th International Conference on European Immunology
Meet leading Immunology Experts, Immunity Health Speakers, Immunologist Researchers, Neuro Immunology Scientists from Amsterdam, Netherlands, New York, Valencia, Frankfurt, London, Dubai, Chicago, France, China, all over the world at European Immunology Conference 2022| May 02-03, 2022 Zurich, Switzerland 35 Ruddlesway, Windsor, Berkshire, SL4 5SF Meet leading Immunology Experts, Immunity Health Speakers, Immunologist Researchers, Neuro Immunology Scientists from Amsterdam, Netherlands, New York, Valencia, Frankfurt, London, Dubai, Chicago, France,โ€ฆ